Identification of Novel Genomic-Variant Patterns of OR56A5, OR52L1, and CTSD in Retinitis Pigmentosa Patients by Whole-Exome Sequencing.
Adult
Aged
Cathepsin D
/ blood
Female
Frameshift Mutation
Gene Ontology
Genetic Predisposition to Disease
Humans
Male
Middle Aged
Muscle Proteins
/ genetics
Mutation, Missense
Pedigree
Perforin
/ genetics
Plasma Membrane Calcium-Transporting ATPases
/ genetics
Polymorphism, Single Nucleotide
Protein Interaction Maps
Retinal Dystrophies
/ congenital
Retinitis Pigmentosa
/ congenital
Risk Factors
Tomography, Optical Coherence
Exome Sequencing
inherited retinal dystrophies
retinitis pigmentosa
whole-exome sequencing
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 May 2021
25 May 2021
Historique:
received:
25
04
2021
revised:
20
05
2021
accepted:
21
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
25
6
2021
Statut:
epublish
Résumé
Inherited retinal dystrophies (IRDs) are rare but highly heterogeneous genetic disorders that affect individuals and families worldwide. However, given its wide variability, its analysis of the driver genes for over 50% of the cases remains unexplored. The present study aims to identify novel driver genes, disease-causing variants, and retinitis pigmentosa (RP)-associated pathways. Using family-based whole-exome sequencing (WES) to identify putative RP-causing rare variants, we identified a total of five potentially pathogenic variants located in genes OR56A5, OR52L1, CTSD, PRF1, KBTBD13, and ATP2B4. Of the variants present in all affected individuals, genes OR56A5, OR52L1, CTSD, KBTBD13, and ATP2B4 present as missense mutations, while PRF1 and CTSD present as frameshift variants. Sanger sequencing confirmed the presence of the novel pathogenic variant PRF1 (c.124_128del) that has not been reported previously. More causal-effect or evidence-based studies will be required to elucidate the precise roles of these SNPs in the RP pathogenesis. Taken together, our findings may allow us to explore the risk variants based on the sequencing data and upgrade the existing variant annotation database in Taiwan. It may help detect specific eye diseases such as retinitis pigmentosa in East Asia.
Identifiants
pubmed: 34070492
pii: ijms22115594
doi: 10.3390/ijms22115594
pmc: PMC8198027
pii:
doi:
Substances chimiques
KBTBD13 protein, human
0
Muscle Proteins
0
PRF1 protein, human
0
Perforin
126465-35-8
CTSD protein, human
EC 3.4.23.5
Cathepsin D
EC 3.4.23.5
ATP2B4 protein, human
EC 3.6.1.8
Plasma Membrane Calcium-Transporting ATPases
EC 3.6.3.8
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Acta Ophthalmol Scand Suppl. 2002;(233):1-34
pubmed: 11921605
N Engl J Med. 2008 Jun 26;358(26):2760-3
pubmed: 18579810
Prog Retin Eye Res. 2014 Sep;42:1-26
pubmed: 24857951
J Ophthalmol. 2015;2015:819760
pubmed: 26161267
J Clin Invest. 2010 Sep;120(9):3042-53
pubmed: 20811160
Nucleic Acids Res. 2021 Jan 8;49(D1):D613-D621
pubmed: 33211851
Nat Genet. 2012 Mar 25;44(5):522-5
pubmed: 22446961
Jpn J Ophthalmol. 2018 Jul;62(4):451-457
pubmed: 29785639
Bioinformatics. 2019 Nov 1;35(22):4854-4856
pubmed: 31192369
PLoS One. 2011 Feb 04;6(2):e16853
pubmed: 21326860
PLoS Genet. 2019 Dec 12;15(12):e1008489
pubmed: 31830040
Nat Rev Genet. 2010 Jun;11(6):446-50
pubmed: 20479774
Cell Cycle. 2007 Mar 15;6(6):652-5
pubmed: 17374995
Nucleic Acids Res. 2017 Jan 4;45(D1):D183-D189
pubmed: 27899595
Eye (Lond). 1998;12 ( Pt 3b):571-9
pubmed: 9775219
N Engl J Med. 2010 Nov 18;363(21):2076-7; author reply 2077
pubmed: 21083406
Genes (Basel). 2019 Jun 14;10(6):
pubmed: 31207907
Curr Opin Neurobiol. 1997 Oct;7(5):666-73
pubmed: 9384551
J Biol Chem. 1995 Dec 15;270(50):30111-4
pubmed: 8530416
Ophthalmic Genet. 2019 Dec;40(6):507-513
pubmed: 31833436
PLoS One. 2012;7(3):e33598
pubmed: 22479419
Nat Rev Drug Discov. 2013 Aug;12(8):581-94
pubmed: 23868113
Nat Rev Genet. 2010 Nov;11(11):773-85
pubmed: 20940738
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
J Neurosci. 2005 Mar 9;25(10):2761-70
pubmed: 15758186
Methods Mol Biol. 2019;1834:3-27
pubmed: 30324433
Mol Vis. 2015 Jul 17;21:783-92
pubmed: 26261414
Retina. 2017 Jun;37(6):1193-1202
pubmed: 27658286
J Neurochem. 2009 Feb;108(3):796-810
pubmed: 19187097
Orphanet J Rare Dis. 2006 Oct 11;1:40
pubmed: 17032466
Invest Ophthalmol Vis Sci. 2012 Feb 27;53(2):1033-40
pubmed: 22302105
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551
pubmed: 33125081
NPJ Genom Med. 2021 Feb 11;6(1):10
pubmed: 33574314
N Engl J Med. 1990 Nov 8;323(19):1302-7
pubmed: 2215617
Mol Psychiatry. 2011 May;16(5):548-56
pubmed: 20386566
Adv Exp Med Biol. 2006;572:3-8
pubmed: 17249547
Lancet. 2006 Nov 18;368(9549):1795-809
pubmed: 17113430
Nucleic Acids Res. 2021 Jan 8;49(D1):D1207-D1217
pubmed: 33264411
Genet Epidemiol. 2011;35 Suppl 1:S41-7
pubmed: 22128057
Cell. 2020 Jul 9;182(1):226-244.e17
pubmed: 32649875
Wiley Interdiscip Rev Syst Biol Med. 2009 Nov-Dec;1(3):390-399
pubmed: 20052305
Plant Methods. 2013 Jul 22;9:29
pubmed: 23876160
Nature. 2008 Nov 6;456(7218):18-21
pubmed: 18987709
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3052-64
pubmed: 16799052
Nat Genet. 2015 Aug;47(8):856-60
pubmed: 26121088
Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45
pubmed: 26553804
PLoS Genet. 2010 Feb 19;6(2):e1000847
pubmed: 20174558
Exp Eye Res. 2004 Aug;79(2):167-73
pubmed: 15325563
Wien Med Wochenschr. 2015 May;165(9-10):210-3
pubmed: 26059544
Surv Ophthalmol. 1999 Jan-Feb;43(4):321-34
pubmed: 10025514
J Hum Genet. 2021 Jan;66(1):11-23
pubmed: 32948841